July 2023: Addressing Needs of Rare Disease Community, Plus New Long-Term Data for Our Uncontrolled Gout Medicine

Take a look at the top five things that happened at Horizon in July.?

1. Horizon Announces 2023 #RAREis Global Advocate Grant Recipients

A total of 50 rare disease patient advocacy organizations – up from 30 in 2022 – have been selected by Horizon to receive a one-time grant of $5,000 each to use toward new programs, educational resources and other offerings to support the rare disease community. Learn more about this year’s #RAREis Global Advocate Grant recipients: https://bit.ly/47j8gCe .?

2. Horizon Named to Fortune’s Best Workplaces for Millennials List

Horizon landed on the Best Workplaces for Millennials list, compiled by Great Place to Work and presented by Fortune, for the fourth consecutive year. The annual rankings are based on survey feedback from more than 413,000 employees at Great Place to Work-certified organizations that employ at least 50 millennials. Learn more about our workplace culture: https://bit.ly/2VucRA8 .

3. From Graves’ Disease to Thyroid Eye Disease (TED): Designer Donna Moss Speaks Out

For Graves’ Disease Awareness Month, former HGTV host and award-winning interior designer Donna Moss shared how a trip to the emergency room led to a Graves' disease diagnosis and inspired her to become an advocate for others. Read her blog post: https://bit.ly/43lrhR7 .

4. Long-Term Data Reinforce Efficacy of Co-Treatment Approach for Uncontrolled Gout Medicine

On July 6, we announced the publication of long-term data from the MIRROR randomized controlled trial for our uncontrolled gout medicine in Open Rheumatology. This analysis extends through Month 12 of treatment using our medicine for gout with the immunomodulator, methotrexate, showing a largely sustained patient response rate and similar safety profile compared with Month 6 findings. Learn more: https://bit.ly/3pCqQEd .

5. Horizon’s Veronica Moore Issues Call to Go Further With Social Determinants of Health (SDOH)

In a new Horizon Stories blog post, Veronica Moore, associate director, patient advocacy, shares her thoughts on the social determinants of health (SDOH) framework in biotech and why it’s so important. Read her blog post: https://bit.ly/3rErNwv .